PubMed:16506214 / 1277-1529 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T10","span":{"begin":0,"end":252},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":252},"obj":"Sentence"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"LitCoin-sentences","denotations":[{"id":"T10","span":{"begin":0,"end":252},"obj":"Sentence"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"LitCoin-entities","denotations":[{"id":"2801","span":{"begin":77,"end":86},"obj":"SequenceVariant"},{"id":"2802","span":{"begin":91,"end":100},"obj":"SequenceVariant"},{"id":"2803","span":{"begin":194,"end":209},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A21","pred":"db_id","subj":"2801","obj":"c|SUB|T|+3100|G"},{"id":"A22","pred":"db_id","subj":"2802","obj":"c|SUB|C|+8365|T"},{"id":"A23","pred":"db_id","subj":"2803","obj":"MESH:D011471"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"LitCoin_Mondo","denotations":[{"id":"T9","span":{"begin":194,"end":209},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T10","span":{"begin":203,"end":209},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"0008315"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"0004992"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T15","span":{"begin":120,"end":129},"obj":"GeneOrGeneProduct"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T26","span":{"begin":120,"end":129},"obj":"GeneOrGeneProduct"},{"id":"T27","span":{"begin":239,"end":244},"obj":"GeneOrGeneProduct"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T8","span":{"begin":194,"end":209},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A8","pred":"originalLabel","subj":"T8","obj":"D011471"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T4","span":{"begin":194,"end":209},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"0008315"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T10","span":{"begin":194,"end":209},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A10","pred":"ID:","subj":"T10","obj":"D011471"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T9","span":{"begin":194,"end":209},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"#label","subj":"T9","obj":"D011471"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T9","span":{"begin":194,"end":209},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"#label","subj":"T9","obj":"D011471"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"PubmedHPO","denotations":[{"id":"T8","span":{"begin":194,"end":209},"obj":"HP_0012125"},{"id":"T9","span":{"begin":203,"end":209},"obj":"HP_0002664"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}

{"project":"tmVarCorpus","denotations":[{"id":"T3","span":{"begin":77,"end":86},"obj":"DNAMutation:c|SUB|T|+3100|G"},{"id":"T4","span":{"begin":91,"end":100},"obj":"DNAMutation:c|SUB|C|+8365|T"}],"text":"In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046)."}